Director Stock Option Grant

Alan Glicklich, a director at CalciMedica, Inc. (CALC), was granted 20,000 stock options on October 1, 2026. These options, exercisable at $1.64 per share, are for CalciMedica's Common Stock and will expire on September 30, 2036. The options vest in monthly installments starting August 19, 2026, over one year, with full vesting by the 2027 annual meeting. This transaction is classified as an OFFICER_DIRECTOR_CHANGE due to the grant of options to a director. The filing is considered to be of MEDIUM importance.